Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Inhibikase Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Inhibikase Therapeutics Inc. June 26, 202677.2%
-
Inhibikase Therapeutics Inc. June 23, 202396.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 30, 2026 | Inhibikase Therapeutics Inc. | Option exercise | +21,854 | $1.26 | $27,536 |
Questions about Dennis N. Berman
What boards is Dennis N. Berman on?
Dennis N. Berman sits on the board of Inhibikase Therapeutics Inc.
How long has Dennis N. Berman served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.